Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?
Barton
Matthias
M
Meyer
Matthias R
MR
Haas
Elvira
E
D000367:Age Factors; D000368:Aged; D000375:Aging / Q000502:physiology*; D050197:Atherosclerosis / Q000453:epidemiology / Q000517:prevention & control; D003324:Coronary Artery Disease / Q000453:epidemiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009640:Norethindrone / Q000627:therapeutic use; D017698:Postmenopause / Q000187:drug effects; D011379:Prognosis; D012307:Risk Factors; D016896:Treatment Outcome
D004958:Estradiol; D009640:Norethindrone